Insulin-induced activation of extracellular signal-regulated kinases [ERKs, also known as mitogen-activated protein (MAP) kinases] is mediated by Ras. Insulin activates Ras primarily by increasing the rate of guanine nucleotide-releasing activity. Here, we show that insulininduced activation of ERKs was enhanced by stable overexpression of growth factor receptor-bound protein 2 (GRB2) but not by overexpression of GRB2 proteins with point mutations in the Src homology 2 and 3 domains. Moreover, a dominant negative form of Ras (with Ser17 substituted with Asn) blocked insulin-induced activation of ERKs in cells that overexpressed GRB2. GRB2 overexpression led to increased formation of a complex between the guanine nucleotide-releasing factor Sos (the product of the mammalian homolog of son ofsevenless gene) and GRB2. In response to insulin stimulation, this complex bound to tyrosine-phosphorylated IRS-1 (insulin receptor substrate-1) and Shc. In contrast to the activated epidermal growth factor receptor that binds the GRB2-Sos complex directly, activation of the insulin receptor results in the interaction of GRB2-Sos with IRS-1 and Shc, thus linking the insulin receptor to Ras signaling pathways.
To determine whether GRB2 is important in mediating activation of Ras in insulinstimulated cells, we constructed stable L6 myoblast cell lines that overexpress either wild-type GRB2 or mutant GRB2
[GRB2(R86K)1 containing a lysine instead of an arginine in the conserved FLVRES motif of the SH2 domain (1, 2) . This mutation inhibits the binding of GRB2 to phosphotyrosine-containing proteins (3) . Activation of ERKs (also known as MAP kinases) by a variety of growth factors is mediated by Ras (4, 5) . Overexpression of GRB2 (approximately fivefold) enhanced the ability of insulin to stimulate tyrosine phosphorylation of the p42erk (ERK-2) and p44er (ERK-1) proteins ( Fig. 1) (6) . Such overexpression led to tyrosine phosphorylation of ERK-1 and ERK-2 at insulin concentrations one-tenth of those normally required for phosphorylation. Intact Src homology 2 and 3 (SH2 and SH3) domains of GRB2 were required for this effect. There was no increase in tyrosine phosphorylation of ERK in cells that overexpressed mutant GRB2 proteins containing either a point mutation in the SH2 domain (R86K) (2) (Fig. 1A) or point mutations in the SH3 domains that correspond to those found in loss-of-function Sem-5 mutants (3, 7, 9) . The increased tyrosine phosphorylation of ERKs in cell lines overexpressing GRB2 did not result simply from a change in the kinetics of ERK phosphorylation; both GRB2-overexpressing cells and control cells exhibited similar kinetics of insulin-induced tyrosine phosphorylation of ERK-1 and ERK-2 (Fig. iB) .
The increase in ERK tyrosine phospho- (4, 5, 14) . To verify that enhancement of ERK activation by GRB2 was mediated by an increase in the activity of Ras, we constructed cell lines that expressed GRB2 and a dominant inhibitor of Ras, Ras(S17N) (2, 15) . This mutant Ras protein has a reduced affinity for guanosine triphosphate and inhibits wild-type Ras activity by interfering with the guanine nucleotide-releasing factor (GNRF) that is normally involved in Ras activation (16) . Cell lines that overexpressed GRB2 were transfected with a plasmid containing Ras(S17N) under the control of an inducible promoter. Expression of Ras (Sl7N) phorylation was correlated with an inhibition of ERK enzymatic activity. These results suggest that in insulin-stimulated cells, GRB2 links the insulin receptor to activation of Ras. Furthermore, activation of ERKs in an insulin-responsive target cell, such as a muscle cell, is mediated by Ras. Because L6 cells contain insulin-like growth factor receptors (IGF-1 receptors) in addition to insulin receptors, the insulin effects described above may be mediated in part by the IGF-1 receptor.
The interaction between GRB2 and GNRF, Sos (the product of the son of sevenless gene), appears to function in the control of Ras signaling by receptor tyrosine kinases (9, (17) (18) (19) --p42erk rich stretches of nine or ten amino acids in target proteins (20) . It has been recently shown that GRB2 binds through its SH2 domain to the epidermal growth factor (EGF) receptor and through its SH3 domains to Sos, thereby coupling receptor tyrosine kinases to Ras signaling pathways (19, 21, 22) . To understand the mechanism whereby overexpression of GRB2 potentiates activation of Ras in response to insulin, we measured the amount of Sos associated with GRB2. GRB2 was immunoprecipitated from both control cells and cells overexpressing GRB2, and the amount of Sos associated with GRB2 was assessed (23) . Overexpression of GRB2 led to the immunoprecipitation of more GRB2, and the increased amount of immunoprecipitated GRB2 was associated with an in-A Insulin _ _ + Antibodies Dex.
--+ A tio:ie p44erk creased amount of co-immunoprecipitating Sos (Fig. 5A) . Insulin stimulation resulted in a mobility shift of Sos in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) that was a result of phosphorylation of Sos on Ser and Thr residues (8) . The increased GRB2-Sos complex detected in cells overexpressing GRB2 was not a result of differences in Sos expression in the two cell lines (Fig. SB) . This finding suggests that under normal conditions, the amount ofSos bound to GRB2 is limited[ by the amount of GRB2 present in the cell. Thus, overexpression of GRB2 apparently potentiates insulin activation of Ras and ERKs by enhancing the formation of an Sos-GRB2 complex, thereby allowing a larger pool of Sos to be recruited to the insulin signaling pathway.
After insulin stimulation, the SH2 domain of GRB2 binds two tyrosine-phosphorylated proteins: insulin receptor substrate-1 (IRS-1) (a major target for the insulin and IGF-1 receptors) and Shc (an SH2 domaincontaining protein that is a target for many tyrosine kinases) (3, 24, 25) . Tyrosine-phosphorylated IRS-1 binds the SH2 domain of p85-associated phosphatidylinositol-3 kinase (PI-3 kinase), thereby activating PI-3 kinase, and cellular overexpression of Shc transforms NIH 3T3 cells and activates Ras in PC-12 cells (24, 25) . The interactions between GRB2, IRS-1, and Shc are likely to be important in the activation of Ras by the insulin receptor. Because insulin-induced stimulation of Ras is mediated through activation of a GNRF (26) , one reasonable hypothesis is that the interaction of GRB2 with IRS-1 or Shc or both enables Sos, bound to the SH3 domain of GRB2, to activate Ras. This is supported by our finding that overexpression of wild-type GRB2, but not of a GRB2 SH2 mutant that is unable to bind IRS-1 or Shc, potentiates the ability of insulin to activate Ras. Furthermore, GRB2 
